PHILADELPHIA, July 31, 2015 /PRNewswire/ -- Parkway Clinical Laboratories, Inc. (PCL), today announced it has received licensing from the State of New York, Department of Public Health. This addition to the list of accreditations of PCL enables it to now provide laboratory services across the United States in all 50 states and the District of Columbia.
"We at PCL are thrilled to join a select group of clinical laboratories that possess licensure from the State of New York," said company Chairman and Chief Executive Officer, Raza Bokhari, MD. "Receiving this coveted accreditation from the State of New York is a critical achievement in fueling our already accelerated growth in providing LC/MS-MS confirmations to pain management specialists and behavioral health providers. It will also enhance our growth in providing service to anti-aging, wellness, holistic and integrative healthcare specialists."
PCL is a College of American Pathologists (CAP) accredited national CLIA-certified clinical reference laboratory performing routine and esoteric diagnostic testing. PCL is focused primarily on serving addiction and pain management specialists as well as supporting anti-aging and wellness providers in the initial diagnosis and ongoing care of patients suffering from complex chronic diseases, nutritional deficiencies and advanced cardiovascular risk. Conveniently located in Bensalem, PA, our primary facility is situated in the northeast suburbs, between downtown Philadelphia and the countryside of Bucks County. The laboratory has been a trusted partner delivering in-vitro diagnostic services for more than four decades.
For more information, contact Director of Marketing and Sales, Carolyn Bonner, at firstname.lastname@example.org.
SOURCE Parkway Clinical Laboratories, Inc.